EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease

Sushma Chowdary Maddipatla, Vasantha L Kolachala, Suresh Venkateswaran, Anne F Dodd, Ranjit Singh Pelia, Duke Geem, Hong Yin, Yutong Sun, Congmin Xu, Angela Mo, Astrid Kosters, Junkai Yang und 4 weitere

Inflammatory Bowel Diseases · 01.02.2023 · 29 (2) · 274-285

DOI: 10.1093/ibd/izac201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 07.10.2022. Verfasst von Sushma Chowdary Maddipatla und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Department of Pediatrics and Pediatric Research Institute, Children's Healthcare of Atlanta, Emory University…. Hauptthemen laut MEDLINE: Crohn Disease. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, Leona M. and Harry B. Helmsley Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Crohn’s disease is a lifelong disease characterized by chronic inflammation of the gastrointestinal tract. Defining the cellular and transcriptional composition of the mucosa at different stages of disease progression is needed for personalized therapy in Crohn’s.

Methods

Ileal biopsies were obtained from (1) control subjects (n = 6), (2) treatment-naïve patients (n = 7), and (3) established (n = 14) Crohn’s patients along with remission (n = 3) and refractory (n = 11) treatment groups. The biopsies processed using 10x Genomics single cell 5' yielded 139 906 cells. Gene expression count matrices of all samples were analyzed by reciprocal principal component integration, followed by clustering analysis. Manual annotations of the clusters were performed using canonical gene markers. Cell type proportions, differential expression analysis, and gene ontology enrichment were carried out for each cell type.

Results

We identified 3 cellular compartments with 9 epithelial, 1 stromal, and 5 immune cell subtypes. We observed differences in the cellular composition between control, treatment-naïve, and established groups, with the significant changes in the epithelial subtypes of the treatment-naïve patients, including microfold, tuft, goblet, enterocyte,s and BEST4+ cells. Surprisingly, fewer changes in the composition of the immune compartment were observed; however, gene expression in the epithelial and immune compartment was different between Crohn’s phenotypes, indicating changes in cellular activity.

Conclusions

Our study identified cellular and transcriptional signatures associated with treatment-naïve Crohn’s disease that collectively point to dysfunction of the intestinal barrier with an increase in inflammatory cellular activity. Our analysis also highlights the heterogeneity among patients within the same disease phenotype, shining a new light on personalized treatment responses and strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseHumansIntestinal MucosaIleumIntestinesInflammation

Stichwörter der Autor:innen

Crohn’s diseaseenterocytesileuminflammatory bowel diseasesingle cell RNA-seq

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Department of Pediatrics and Pediatric Research Institute, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
  • Department of Pathology, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.
  • School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
  • Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.
  • School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.
  • Lowance Center for Human Immunology, Division of Immunology and Rheumatology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

ORCID-Profile: Subra Kugathasan

Förderung

  • NIH HHS
  • NIDDK NIH HHS
  • Leona M. and Harry B. Helmsley Charitable Trust
  • National Science Foundation

Zitieren

APA

Maddipatla, S. C., Kolachala, V. L., Venkateswaran, S., Dodd, A. F., Pelia, R. S., Geem, D., Yin, H., Sun, Y., Xu, C., Mo, A., Kosters, A., Yang, J., Matthews, J. D., Ghosn, E., Kugathasan, S., & Qiu, P. (2023). Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease. Inflammatory Bowel Diseases, 29(2), 274-285. https://doi.org/10.1093/ibd/izac201

Vancouver

Maddipatla SC, Kolachala VL, Venkateswaran S, Dodd AF, Pelia RS, Geem D, et al. Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease. Inflammatory Bowel Diseases. 2023;29(2):274-285. doi:10.1093/ibd/izac201

BibTeX
@article{Maddipatla2023,
  author = {Maddipatla, Sushma Chowdary and Kolachala, Vasantha L and Venkateswaran, Suresh and Dodd, Anne F and Pelia, Ranjit Singh and Geem, Duke and Yin, Hong and Sun, Yutong and Xu, Congmin and Mo, Angela and Kosters, Astrid and Yang, Junkai and Matthews, Jason D and Ghosn, Eliver and Kugathasan, Subra and Qiu, Peng},
  title = {Assessing Cellular and Transcriptional Diversity of Ileal Mucosa Among Treatment-Naïve and Treated Crohn’s Disease},
  journal = {Inflammatory Bowel Diseases},
  year = {2023},
  volume = {29},
  number = {2},
  pages = {274--285},
  doi = {10.1093/ibd/izac201}
}
Kostenlos starten →